Design Therapeutics Inc (DSGN) PT Raised to $20 at RBC Capital May 18, 2026 09:35AM
'Design Therapeutics Inc (DSGN) Remains On Track For 2H Catalysts'; PT Raised at RBC Capital Mar 10, 2026 08:44AM
RBC Capital Upgrades Design Therapeutics Inc (DSGN) to Outperform Nov 20, 2025 05:05AM
RBC Capital Reiterates Sector Perform Rating on Design Therapeutics Inc (DSGN) Jun 4, 2025 08:10AM
Design Therapeutics to Participate in 2025 RBC Capital Markets Healthcare Conference May 13, 2025 08:00AM


May 7, 2024 06:30AM Design Therapeutics to Participate in the 2024 RBC Capital Markets Global Healthcare Conference
Aug 15, 2023 06:44AM RBC Capital Downgrades Design Therapeutics Inc (DSGN) to Sector Perform 'pending further derisking'
May 9, 2022 04:05PM Design Therapeutics Highlights Clinical and Research Progress and Reports First Quarter 2022 Financial Results
May 9, 2022 04:05PM Design Therapeutics Highlights Clinical and Research Progress and Reports First Quarter 2022 Financial Results